A Phase 2, Single-center, Single-arm, Open Label Trial of Vismodegib in Patients With Keratocystic Odontogenic Tumors

NCT02366312 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Keratocystic Odontogenic Tumor

Interventions

DRUG: vismodegib

Sponsor

NYU College of Dentistry

Collaborators

[object Object]